Prognostic factors in patients with advanced thymic carcinoma treated with chemotherapy: A retrospective analysis of 289 patients from NEJ023 Study. Second-line chemotherapy efficacy in patients with ...
All runs Wins only Wins & places After 60-day break ...
Association of immune-related adverse events with survival and treatment outcomes in thymic tumors treated with immune checkpoint inhibitors. Comparing impact of treatment before or after surgery in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback